Genetics of Dilated Cardiomyopathy: Clinical Implications

A. Paldino, G. De Angelis, M. Merlo, M. Gigli, M. Dal Ferro, G. M. Severini, L. Mestroni, G. Sinagra

Research output: Contribution to journalReview article

Abstract

Purpose of Review: This review aims to summarize the current knowledge on the genetic background of dilated cardiomyopathy (DCM), with particular attention to the genotype-phenotype correlations and the possible implications for clinical management. Recent Findings: Next generation sequencing (NGS) has led to the identification of an increasing number of genes and mutations responsible for DCM. This genetic variability is probably related to the extreme heterogeneity of disease manifestation. Important findings have associated mutations of Lamin A/C (LMNA) and Filamin C (FLNC) to poor prognosis and the propensity to cause an arrhythmic phenotype, respectively. However, a deeper understanding of the genotype-phenotype correlation is necessary, because it could have several implications for the clinical management of the patients. Furthermore, the correct interpretation of pathogenicity of mutations and the clinical impact of genetic testing in DCM patients still represent important fields to be implemented. Summary: A pathogenic gene mutation can be identified in almost 40% of DCM patients. The recent discoveries and future research in the field of genotype-phenotype correlation may lead to a more personalized management of the mutation carriers towards the application of precision medicine in DCM.

Original languageEnglish
Article number83
JournalCurrent Cardiology Reports
Volume20
Issue number10
DOIs
Publication statusPublished - Oct 1 2018

Fingerprint

Dilated Cardiomyopathy
Genetic Association Studies
Mutation
Filamins
Lamin Type A
Precision Medicine
Genetic Testing
Genes
Virulence
Phenotype

Keywords

  • Dilated cardiomyopathy
  • Filamin C
  • Genotype-phenotype correlation
  • Lamin A/C
  • Next generation sequencing
  • Precision medicine

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Genetics of Dilated Cardiomyopathy : Clinical Implications. / Paldino, A.; De Angelis, G.; Merlo, M.; Gigli, M.; Dal Ferro, M.; Severini, G. M.; Mestroni, L.; Sinagra, G.

In: Current Cardiology Reports, Vol. 20, No. 10, 83, 01.10.2018.

Research output: Contribution to journalReview article

Paldino, A, De Angelis, G, Merlo, M, Gigli, M, Dal Ferro, M, Severini, GM, Mestroni, L & Sinagra, G 2018, 'Genetics of Dilated Cardiomyopathy: Clinical Implications', Current Cardiology Reports, vol. 20, no. 10, 83. https://doi.org/10.1007/s11886-018-1030-7
Paldino, A. ; De Angelis, G. ; Merlo, M. ; Gigli, M. ; Dal Ferro, M. ; Severini, G. M. ; Mestroni, L. ; Sinagra, G. / Genetics of Dilated Cardiomyopathy : Clinical Implications. In: Current Cardiology Reports. 2018 ; Vol. 20, No. 10.
@article{b640a74050034941a917c5ca68955179,
title = "Genetics of Dilated Cardiomyopathy: Clinical Implications",
abstract = "Purpose of Review: This review aims to summarize the current knowledge on the genetic background of dilated cardiomyopathy (DCM), with particular attention to the genotype-phenotype correlations and the possible implications for clinical management. Recent Findings: Next generation sequencing (NGS) has led to the identification of an increasing number of genes and mutations responsible for DCM. This genetic variability is probably related to the extreme heterogeneity of disease manifestation. Important findings have associated mutations of Lamin A/C (LMNA) and Filamin C (FLNC) to poor prognosis and the propensity to cause an arrhythmic phenotype, respectively. However, a deeper understanding of the genotype-phenotype correlation is necessary, because it could have several implications for the clinical management of the patients. Furthermore, the correct interpretation of pathogenicity of mutations and the clinical impact of genetic testing in DCM patients still represent important fields to be implemented. Summary: A pathogenic gene mutation can be identified in almost 40{\%} of DCM patients. The recent discoveries and future research in the field of genotype-phenotype correlation may lead to a more personalized management of the mutation carriers towards the application of precision medicine in DCM.",
keywords = "Dilated cardiomyopathy, Filamin C, Genotype-phenotype correlation, Lamin A/C, Next generation sequencing, Precision medicine",
author = "A. Paldino and {De Angelis}, G. and M. Merlo and M. Gigli and {Dal Ferro}, M. and Severini, {G. M.} and L. Mestroni and G. Sinagra",
year = "2018",
month = "10",
day = "1",
doi = "10.1007/s11886-018-1030-7",
language = "English",
volume = "20",
journal = "Current Cardiology Reports",
issn = "1523-3782",
publisher = "Current Medicine Group",
number = "10",

}

TY - JOUR

T1 - Genetics of Dilated Cardiomyopathy

T2 - Clinical Implications

AU - Paldino, A.

AU - De Angelis, G.

AU - Merlo, M.

AU - Gigli, M.

AU - Dal Ferro, M.

AU - Severini, G. M.

AU - Mestroni, L.

AU - Sinagra, G.

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Purpose of Review: This review aims to summarize the current knowledge on the genetic background of dilated cardiomyopathy (DCM), with particular attention to the genotype-phenotype correlations and the possible implications for clinical management. Recent Findings: Next generation sequencing (NGS) has led to the identification of an increasing number of genes and mutations responsible for DCM. This genetic variability is probably related to the extreme heterogeneity of disease manifestation. Important findings have associated mutations of Lamin A/C (LMNA) and Filamin C (FLNC) to poor prognosis and the propensity to cause an arrhythmic phenotype, respectively. However, a deeper understanding of the genotype-phenotype correlation is necessary, because it could have several implications for the clinical management of the patients. Furthermore, the correct interpretation of pathogenicity of mutations and the clinical impact of genetic testing in DCM patients still represent important fields to be implemented. Summary: A pathogenic gene mutation can be identified in almost 40% of DCM patients. The recent discoveries and future research in the field of genotype-phenotype correlation may lead to a more personalized management of the mutation carriers towards the application of precision medicine in DCM.

AB - Purpose of Review: This review aims to summarize the current knowledge on the genetic background of dilated cardiomyopathy (DCM), with particular attention to the genotype-phenotype correlations and the possible implications for clinical management. Recent Findings: Next generation sequencing (NGS) has led to the identification of an increasing number of genes and mutations responsible for DCM. This genetic variability is probably related to the extreme heterogeneity of disease manifestation. Important findings have associated mutations of Lamin A/C (LMNA) and Filamin C (FLNC) to poor prognosis and the propensity to cause an arrhythmic phenotype, respectively. However, a deeper understanding of the genotype-phenotype correlation is necessary, because it could have several implications for the clinical management of the patients. Furthermore, the correct interpretation of pathogenicity of mutations and the clinical impact of genetic testing in DCM patients still represent important fields to be implemented. Summary: A pathogenic gene mutation can be identified in almost 40% of DCM patients. The recent discoveries and future research in the field of genotype-phenotype correlation may lead to a more personalized management of the mutation carriers towards the application of precision medicine in DCM.

KW - Dilated cardiomyopathy

KW - Filamin C

KW - Genotype-phenotype correlation

KW - Lamin A/C

KW - Next generation sequencing

KW - Precision medicine

UR - http://www.scopus.com/inward/record.url?scp=85051666769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051666769&partnerID=8YFLogxK

U2 - 10.1007/s11886-018-1030-7

DO - 10.1007/s11886-018-1030-7

M3 - Review article

AN - SCOPUS:85051666769

VL - 20

JO - Current Cardiology Reports

JF - Current Cardiology Reports

SN - 1523-3782

IS - 10

M1 - 83

ER -